Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 28,750
+475 (1.68%)
Jul 21, 2026, 1:00 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 600.83 billion as of July 20, 2026. Its market cap has decreased by -17.20% in one year.
Market Cap
600.83B
Enterprise Value
578.69B
Revenue
69.29B
Ranking
n/a
PE Ratio
38.71
Stock Price
28,750.00
ChartMarket Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 600.83B, an increase of 12,497.90%. That is a compound annual growth rate of 21.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 600.83B | -2.73% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.15T |
| Mankind Pharma | 1.06T |
| Aurobindo Pharma | 897.36B |
| Laurus Labs | 841.58B |
| Alkem Laboratories | 675.88B |
| Glenmark Pharmaceuticals | 631.99B |
| Ipca Laboratories | 466.46B |
| Ajanta Pharma | 433.24B |